SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oncothyreon

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (2148)5/16/2013 12:27:14 PM
From: scaram(o)uche   of 2344
 
Thanks! Voiced this opinion, in a different thread....

I want to be clear about this. If you go to FDA with interesting results, they logically get interested. They're good scientists who want to help patients. The route with this vaccine is clear.

Cytotoxic T cells, as I've mentioned many times over the years, can eat their way into Fort Knox. These results are real, the questions are whether they're mediated by "adjuvant effects" (foremost including, chuckle, adjuvant) or by antigen sensitization, and, if occasional long-term survivors stand out, can the frequency be goosed by ipi or such?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext